Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic

Int J Infect Dis. 2021 Feb:103:395-401. doi: 10.1016/j.ijid.2020.12.011. Epub 2020 Dec 10.

Abstract

Objectives: This study aimed to compare the risk of infection of children with that of adults and to explore risk factors of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by following up close contacts of COVID-19 patients.

Method: The retrospective cohort study was performed among close contacts of index cases diagnosed with COVID-19 in Guangzhou, China. Demographic characteristics, clinical symptoms and exposure information were extracted. Logistic regression analysis was employed to explore the risk factors. The restricted cubic spline was conducted to examine to the dose-response relationship between age and SARS-CoV-2 infection.

Results: The secondary attack rate (SAR) was 4.4% in 1,344 close contacts. The group of household contacts (17.2%) had the highest SAR. The rare-frequency contact (p < 0.001) and moderate-frequency contact (p < 0.001) were associated with lower risk of infection. Exposure to index cases with dry cough symptoms was associated with infection in close contacts (p = 0.004). Compared with children, adults had a significantly increased risk of infection (p = 0.014). There is a linear positive correlation between age and infection (p = 0.001).

Conclusions: Children are probably less susceptible to COVID-19. Close contacts with frequent contact with patients and those exposed to patients with cough symptoms are associated with an increased risk of infection.

Keywords: COVID-19; Children; Household contact; Secondary attack rate.

MeSH terms

  • Adult
  • Age Factors
  • COVID-19 / transmission*
  • Child
  • China / epidemiology
  • Cohort Studies
  • Contact Tracing
  • Disease Susceptibility / epidemiology
  • Epidemics
  • Family Characteristics
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2